loadpatents
name:-0.13916802406311
name:-0.031578063964844
name:-0.0017027854919434
Lefker; Bruce A. Patent Filings

Lefker; Bruce A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lefker; Bruce A..The latest application filed is for "pyrimidone compounds as gsk-3 inhibitors".

Company Profile
0.23.31
  • Lefker; Bruce A. - Gales Ferry CT
  • Lefker; Bruce A - Gales Ferry CT
  • Lefker; Bruce A. - Galas Ferry CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrimidone Compounds As GSK-3 Inhibitors
App 20100292205 - Lefker; Bruce A. ;   et al.
2010-11-18
Gpr 119 Modulators
App 20100285145 - Darout; Etzer ;   et al.
2010-11-11
Androgen modulators
Grant 7,799,823 - Barrett , et al. September 21, 2
2010-09-21
Androgen modulators
Grant 7,674,819 - Barrett , et al. March 9, 2
2010-03-09
Androgen modulators
Grant 7,670,613 - Hu , et al. March 2, 2
2010-03-02
Androgen Modulators
App 20100048517 - Hu; Lain-Yen ;   et al.
2010-02-25
Androgen receptor modulators
Grant 7,576,128 - Hu , et al. August 18, 2
2009-08-18
Androgen Modulators
App 20090192202 - Hu; Lain-Yen ;   et al.
2009-07-30
Androgen modulators
Grant 7,507,860 - Hu , et al. March 24, 2
2009-03-24
Cyclopentapyridine and tetrahydroquinoline derivatives
Grant 7,507,732 - Lefker , et al. March 24, 2
2009-03-24
Androgen modulators
Grant 7,473,711 - Hu , et al. January 6, 2
2009-01-06
Prostaglandin agonists
Grant 7,442,702 - Cameron , et al. October 28, 2
2008-10-28
Methods of treatment with selective EP4 receptor agonists
Grant 7,414,071 - Cameron , et al. August 19, 2
2008-08-19
Benzonitrile Derivatives to Treat Musculoskeletal Frailty
App 20080045504 - Gant; Thomas G. ;   et al.
2008-02-21
Androgen modulators
App 20070197641 - Hu; Lain-Yen ;   et al.
2007-08-23
Androgen modulators
App 20070197642 - Hu; Lain-Yen ;   et al.
2007-08-23
Androgen Modulators
App 20070072936 - Barrett; Stephen Douglas ;   et al.
2007-03-29
EP4 receptor selective agonist in the treatment of osteoporosis
Grant 7,192,979 - Cameron , et al. March 20, 2
2007-03-20
Androgen modulators
App 20060252796 - Barrett; Stephen Douglas ;   et al.
2006-11-09
Cyclopentapyridine and tetrahydroquinoline derivatives
App 20060247254 - Lefker; Bruce A. ;   et al.
2006-11-02
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
Grant 6,998,423 - Cameron , et al. February 14, 2
2006-02-14
Androgen modulators
App 20060009427 - Hu; Lain-Yen ;   et al.
2006-01-12
Androgen receptor modulators
App 20050182132 - Hu, Lain-Yen ;   et al.
2005-08-18
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-ac etic acid
Grant 6,852,863 - Cameron , et al. February 8, 2
2005-02-08
EP4 receptor selective agonists in the treatment of osteoporosis
App 20040259921 - Cameron, Kimberly O. ;   et al.
2004-12-23
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20040192685 - Cameron, Kimberly O. ;   et al.
2004-09-30
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
App 20040176461 - Cameron, Kimberly O. ;   et al.
2004-09-09
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,747,054 - Cameron , et al. June 8, 2
2004-06-08
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,737,437 - Cameron , et al. May 18, 2
2004-05-18
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20030220494 - Cameron, Kimberly O. ;   et al.
2003-11-27
Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-meth- yl}-phenoxy)-acetic acid
App 20030216445 - Cameron, Kimberly O. ;   et al.
2003-11-20
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
Grant 6,649,657 - Cameron , et al. November 18, 2
2003-11-18
Methods of treatment with selective EP4 receptor agonists
App 20030207925 - Cameron, Kimberly O. ;   et al.
2003-11-06
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,642,266 - Cameron , et al. November 4, 2
2003-11-04
Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
App 20030176479 - Cameron, Kimberly O. ;   et al.
2003-09-18
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
Grant 6,608,203 - Cameron , et al. August 19, 2
2003-08-19
EP4 receptor selective agonists in the treatment of osteoporosis
App 20030149086 - Cameron, Kimberly O. ;   et al.
2003-08-07
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
App 20030105092 - Cameron, Kimberley Q. ;   et al.
2003-06-05
Prostaglandin agonists
App 20030078261 - Cameron, Kimberly O. ;   et al.
2003-04-24
Prostaglandin agonists and their use to treat bone disorders
Grant 6,498,172 - Cameron , et al. December 24, 2
2002-12-24
Osteoporosis compounds
App 20020165255 - Cameron, Kimberly O. ;   et al.
2002-11-07
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
Grant 6,426,359 - Cameron , et al. July 30, 2
2002-07-30
EP4 receptor selective agonists in the treatment of osteoporosis
App 20020065308 - Cameron, Kimberly O. ;   et al.
2002-05-30
Growth-hormone secretagogues
App 20020049196 - Carpino, Philip A. ;   et al.
2002-04-25
EP4 receptor selective agonists in the treatment of osteoporosis
App 20020040149 - Cameron, Kimberly O. ;   et al.
2002-04-04
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
App 20020016368 - Cameron, Kimberly O. ;   et al.
2002-02-07
Use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
App 20020013320 - Busch, Frank Robert ;   et al.
2002-01-31
Treatment of osteoporsis with EP2/EP4 receptor selective agonists
App 20010056060 - Cameron, Kimberly O. ;   et al.
2001-12-27
EP4 receptor selective agonists in the treatment of osteoporosis
App 20010047105 - Cameron, Kimberly O. ;   et al.
2001-11-29
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20010039285 - Cameron, Kimberly O. ;   et al.
2001-11-08
Osteoporosis compounds
Grant 6,124,314 - Cameron , et al. September 26, 2
2000-09-26
Heterocyclic compounds
Grant 6,107,306 - Carpino , et al. August 22, 2
2000-08-22
Dipeptides which promote release of growth hormone
Grant 5,936,089 - Carpino , et al. August 10, 1
1999-08-10
Orally active renin inhibitors
Grant 5,442,044 - Hoover , et al. August 15, 1
1995-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed